Cell and Gene Therapy Supply Chain/Logistics Market expected to Witness Huge Revenue Growth to 2031

InsightAce Analytic announces the release of market assessment report on "Global Cell and Gene Therapy Supply Chain/Logistics Market (By Application area (Donor eligibility assessment, Sample collection, Manufacturing, Logistics, Patient verification and treatment follow-up), By Type of software solution (Cell orchestration platform, Enterprise manufacturing system, Inventory management system, Laboratory information management system, Logistics management system, Patient management system, Quality management system, Tracking and tracing system), By Mode of Deployment (Cloud-based solution, On-premises solution), By End-user (Biobank, Cell therapy lab, Hospital, Research institute, Commercial organization)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast Till 2031".

The Cell and Gene Therapy Supply Chain/Logistics Market Size is valued at 1.35 Billion in 2023 and is predicted to reach 3.17 Billion by the year 2031 at a 11.41 % CAGR during the forecast period for 2024-2031.

Get A Free Report Brochure: https://www.insightaceanalytic.com/request-sample/1694

The supply chain management services for cells and therapies provide customizable services to support a variety of supply chain stages. Providing smart packaging and personalized remedies is a significant challenge in this market. Supply chains' challenging circumstances and requirements exacerbate the demand for even more advanced IT solutions. Most pharmaceutical companies are collaborating with IT companies to simplify and automate their services. Supply chain information control systems that utilize advanced technology enable you to manage, manipulate, and monitor supply chains with the ease of a few clicks. For example, Marken is currently creating technology specifically designed to address the challenges of complex logistics and provide the most effective supply chain solutions for the rapidly expanding cellular and gene therapies market.

The Cell and Gene Therapy Supply Chain/Logistics market is expected to experience a significant increase in the future years due to the ongoing enhancements in supply chain management offerings. The quality of supply chain management services is anticipated to be improved during the forecast period due to the increasing demand for cell and gene treatments, the expansion of medical trials, and the advancements in real-time supply chain operations.

Furthermore, the market expansion is driven by the increasing efficiency of CGT supply chain services, the development of medical technologies, the rise of customizable facilities, and the increasing innovations in supply services. Nevertheless, the market growth over the projected period may be impeded by the excessive funding cost required for CGT supply chain services, the absence of standard therapy protocols, and the complexity of the tactics. The North American region is the primary revenue holder of this market in terms of region. This is due to the high demand for novel therapies, the increasing government investments in the research and development of cell therapies to treat various diseases, and the growing awareness of cell therapies. Additionally, the Asia-Pacific market is anticipated to expand faster due to the improving efficacy of CGT supply chain services and the expansion of cell therapy manufacturing industries.

Order this Premium Report: https://www.insightaceanalytic.com/buy-report/1694

Some of the key players in the Cell and Gene Therapy Supply Chain/Logistics market are Modality Solutions, Almac, Arvato Supply Chain Solutions SE, Catalent, Inc, BioLife Solutions, Inc, Biostor Ltd, Yourway Biopharma Services Company, Atelerix Ltd and Other Prominent Players., Be The Match BioTherapies, MAK-SYSTEM, Cryoport, Brooks Life Sciences, Lykan Bioscience, Clarkston Consulting, SAP, Hypertrust Patient Data Care, Haemonetics, MasterControl, TraceLink, SAVSU Technologies, TrakCel, Title21 Health Solutions, sedApta Group, Vineti, Stafa Cellular Therapy, Thermo Fisher Scientific(Patheon), McKesson, Biocair, Marken(UPS Company),

The primary objective of the most prominent manufacturers in this sector is to provide clients with services that are both customizable and of high quality. Additionally, market participants are leveraging partnerships, collaborations, mergers, and acquisitions to enhance their operations.

Key developments in the market:
In Jan 2023,
Cryoport and Syneos Health have partnered strategically to enhance cell and gene therapies. The partnership will facilitate the advancement of cell and gene therapies worldwide and serve as the organization's inaugural integrated biopharmaceutical and supply chain solution. This agreement will facilitate the acceleration of treatment and enhance outcomes by providing more individuals worldwide with access to these life-changing therapies.

In Oct 2022, TrakCel and ZS collaborated to advance cell and gene orchestration using AI-based solutions. The objective of the TrakCel and ZS partnership was to contribute proactive analysis and forecasting to reduce further treatment delays, product loss, and resource waste, thereby reducing the global cost of CGTs. The partnership aimed to extend supply chain orchestration beyond the visibility of supply chain progress into end-to-end order orchestration implementation and the ability to take immediate action to the planning to modify and improve the supply chain in order to increase efficiencies and decrease delivery times and costs.

Get Specific Chapter/Information From The Report: https://www.insightaceanalytic.com/customisation/1694

In March 2021, Become the perfect match In anticipation of the forthcoming commercial launch of LibmeldyTM (autologous CD34+ cells encoding the ARSA gene), Orchard Therapeutics' recently approved gene therapy in Europe for the treatment of early-onset metachromatic leukodystrophy (MLD), BioTherapies and Orchard Therapeutics had expanded their multi-year partnership to extend to supply chain services.

Market Segments
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Application Area
• Donor eligibility assessment
• Sample collection
• Manufacturing
• Logistics
• Patient verification and treatment follow-up
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Type of Software Solution
• Cell orchestration platform
• Enterprise manufacturing system
• Inventory management system
• Laboratory information management system
• Logistics management system
• Patient management system
• Quality management system
• Tracking and tracing system
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on End-User
• Biobank
• Cell Therapy Lab
• Hospital
• Research Institute
• Commercial Organization

Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Type of Deployment
• Cloud-Based
• On-premises
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

North America Cell and Gene Therapy Supply Chain/Logistics market revenue (US$ Million) by Country, 2023 to 2031
• U.S.
• Canada
Europe Cell and Gene Therapy Supply Chain/Logistics market revenue (US$ Million) by Country, 2023 to 2031
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Cell and Gene Therapy Supply Chain/Logistics market revenue (US$ Million) by Country, 2023 to 2031
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Cell and Gene Therapy Supply Chain/Logistics market revenue (US$ Million) by Country, 2023 to 2031
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa Cell and Gene Therapy Supply Chain/Logistics market revenue (US$ Million) by Country, 2023 to 2031
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Why should buy this report:
> To obtain a thorough examination of the global Cell and Gene Therapy Supply Chain/Logistics market's prospective
> To obtain an industry overview and future trends of the global Cell and Gene Therapy Supply Chain/Logistics market
> To examine the drivers and challenges of the Cell and Gene Therapy Supply Chain/Logistics market
> To acquire data regarding the Cell and Gene Therapy Supply Chain/Logistics market size value (US$ Mn) forecast through 2031
> Major Investments, Mergers, and Acquisitions in the global Cell and Gene Therapy Supply Chain/Logistics Market Industry

Details insights on this market: https://www.insightaceanalytic.com/report/cell-and-gene-therapy-supply-chain-logistics-market/1694

Corporate Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
Sales Office (U.S.) :
344 Grove St Unit #967 Jersey City, NJ 07302
email: info@insightaceanalytic.com
North America:
+1 551 226 6109
Asia:
+91 79 72967118

Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/InsightaceA

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.